Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11952601 Recombinant botulinum toxin with increased duration of effect

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 20, 2017
0
Date of Patent
April 9, 2024
0
Patent Application Number
16498193
0
Patent Citations
‌
US Patent 8444991 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
0
‌
US Patent 8563521 Biological active proteins having increased in vivo and/or in vitro stability
0
‌
US Patent 8748151 Clostridial neurotoxins with altered persistency
0
‌
US Patent 8808710 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
0
‌
US Patent 9050246 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
0
‌
US Patent 9050336 None
0
‌
US Patent 9260494 Biological active proteins having increased in vivo and/or in vitro stability
0
‌
US Patent 9388394 Vaccines against clostridium difficile comprising recombinant toxins
0
‌
US Patent 9758573 Methods to protect against and treat multiple sclerosis
0
‌
US Patent 9809809 Neurotoxins exhibiting shortened biological activity
0
•••
Patent Inventor Names
Manuela López De La Paz
0
Marcel Jurk
0
Daniel Scheps
0
Jürgen Frevert
0
Fred Hofmann
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11952601
0
Patent Primary Examiner
‌
Marsha Tsay
0

Find more entities like US Patent 11952601 Recombinant botulinum toxin with increased duration of effect

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.